Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases
David S. Goldstein, Mark J. Pekker, Graeme Eisenhofer, Yehonatan Sharabi
David S. Goldstein, Mark J. Pekker, Graeme Eisenhofer, Yehonatan Sharabi
View: Text | PDF
Clinical Research and Public Health Cardiology Neuroscience

Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases

  • Text
  • PDF
Abstract

BACKGROUND Lewy body diseases, a family of aging-related neurodegenerative disorders, entail loss of the catecholamine dopamine in the nigrostriatal system and equally severe deficiency of the closely related catecholamine norepinephrine in the heart. The myocardial noradrenergic lesion is associated with major nonmotor symptoms and decreased survival. Numerous mechanisms determine norepinephrine stores, and which of these are altered in Lewy body diseases has not been examined in an integrated way. We used a computational modeling approach to assess comprehensively pathways of cardiac norepinephrine synthesis, storage, release, reuptake, and metabolism in Lewy body diseases. Application of a potentially novel kinetic model identified a pattern of dysfunctional steps contributing to norepinephrine deficiency. We then tested predictions from the model in a new cohort of Parkinson disease patients.METHODS Rate constants were calculated for 17 reactions determining intraneuronal norepinephrine stores. Model predictions were tested by measuring postmortem apical ventricular concentrations and concentration ratios of catechols in controls and patients with Parkinson disease.RESULTS The model identified low rate constants for 3 types of processes in the Lewy body group: catecholamine biosynthesis via tyrosine hydroxylase and aromatic l-amino acid decarboxylase, vesicular storage of dopamine and norepinephrine, and neuronal norepinephrine reuptake via the cell membrane norepinephrine transporter. Postmortem catechols and catechol ratios confirmed this triad of model-predicted functional abnormalities.CONCLUSION Denervation-independent impairments of neurotransmitter biosynthesis, vesicular sequestration, and norepinephrine recycling contribute to the myocardial norepinephrine deficiency attending Lewy body diseases. A proportion of cardiac sympathetic nerves are “sick but not dead,” suggesting targeted disease modification strategies might retard clinical progression.FUNDING Division of Intramural Research, NINDS.

Authors

David S. Goldstein, Mark J. Pekker, Graeme Eisenhofer, Yehonatan Sharabi

×

Figure 5

Box-and-whisker plots for postmortem indices of sympathetic intraneuronal functions in controls and PD patients.

Options: View larger image (or click on image) Download as PowerPoint
Box-and-whisker plots for postmortem indices of sympathetic intraneurona...
Highest, third quartile, median, second quartile, and lowest values are shown. Numbers in italics are P values for independent-means t tests conducted on log-transformed data comparing the control and PD groups. DHPG/NE and DOPAC/NE ratios provided inverse indices of VMAT2 activity. The sum of Cys-DOPA and DOPA, divided by the sum of DA and its metabolites DOPAC and 3,4-dihydroxyphenylethanol, provided an inverse index of LAAAD activity. The sum of Cys-DOPA and DOPA, adjusted for LAAAD activity, provided an index of TH activity. The results indicate decreased VMAT2, LAAAD, and TH activities in PD (shown in red) compared with controls (shown in gray). DHPG/NE: control, n = 11; PD, n = 7. DOPAC/NE: control, n = 11; PD, n = 11. Inv, Index of LAAD: control, n = 11; PD, n = 11. Index of TH: control, n = 11; PD, n = 11. DOPAC, 3,4-dihydroxyphenylacetic acid; Inv., inverse.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts